MedTrace Logo

Urine Proteome of Surgical Patients and Healthy Volunteers

NCT01538823 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 664

Last updated 2019-01-07

No results posted yet for this study

Summary

The purpose of this study is to define early urinary biomarkers for diagnosis and prognosis of Renal Cell Carcinoma (RCC) with subsequent development of reliable, cost-effective, screening techniques.

Conditions

  • Renal Cell Cancer

Sponsors & Collaborators

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Jerry Morrissey, PhD · Washington University School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01538823 on ClinicalTrials.gov